Marken Healthtech Limited
Marken Healthtech Limited
INE0VE701013
Incorporation Date: 26-Mar-2024
Listing Status: DRHP Not Filed
About Marken Healthtech Limited
Overview of Marken Healthtech Limited
MarkEn HealthTech Limited (operating via Marken World) is an Indian company engaged in the medical equipment manufacturing and healthcare infrastructure solutions space. Headquartered in Nashik, Maharashtra, the company focuses on delivering specialized products and turnkey solutions across healthcare cold chain, hospital infrastructure, and refrigeration systems.
With over two decades of legacy experience, the company positions itself as a technology-driven healthcare solutions provider catering to both institutional and government clients.
Business Overview
MarkEn operates in the medical equipment and healthcare infrastructure segment, with an integrated offering spanning manufacturing, project execution, and after-sales services.
- Core focus on medical cold chain and hospital infrastructure solutions
- Operates as a B2B solutions provider for hospitals, labs, and institutions
- Provides both products and turnkey project execution
- Headquartered in Nashik with nationwide service presence
- Serves government bodies, defense institutions, and private healthcare players
The company’s business model revolves around end-to-end healthcare infrastructure delivery rather than standalone product sales.
Product & Solutions Portfolio
MarkEn offers a wide and specialized portfolio focused on healthcare and refrigeration technologies.
Key product categories
- Medical cold chain equipment (vaccine refrigerators, freezers)
- Blood bank equipment and storage systems
- Modular operation theatres (OTs)
- Medical gas pipeline systems
- Hospital furniture and infrastructure
- Commercial refrigeration systems
Specialized offerings
- Vaccine transportation solutions (e.g., insulated vaccine vans)
- Temperature-controlled storage for pharmaceuticals
- Lab and diagnostic equipment
The company has 50+ certified products and focuses heavily on compliance-driven manufacturing.
Manufacturing & Capabilities
MarkEn emphasizes engineering precision and regulatory compliance in its operations.
- Over 25 years of industry experience in cold chain solutions
- Multiple ISO certifications and WHO-PQS compliant products
- Products tested through accredited laboratories
- Strong focus on temperature-controlled technology and refrigeration systems
- Integrated capabilities across design, manufacturing, and installation
This enables the company to operate in highly regulated healthcare environments.
Business Model & Execution
The company differentiates itself through its turnkey project approach.
-
Offers end-to-end project execution:
- Design
- Supply
- Installation
- Commissioning
- Single-point accountability for healthcare infrastructure projects
- Provides post-installation support and maintenance services
- Focus on large institutional orders and long-term contracts
This model allows MarkEn to capture higher value per client compared to product-only companies.
Market Presence & Clients
MarkEn has built a strong presence across institutional healthcare segments.
- Serves 20,000+ customers across India
- Supported by 500+ service centers nationwide
-
Clients include:
- Government healthcare programs
- Hospitals and diagnostic labs
- Research institutions
- Defense sector
The company also participates in global healthcare exhibitions, indicating expanding international ambitions.
Industry Positioning
MarkEn operates within the medical equipment and healthcare infrastructure industry, a niche but high-growth segment.
- Positioned in cold chain + hospital infrastructure solutions
-
Competes with:
- Specialized equipment manufacturers
- Large healthcare infrastructure companies
-
Benefits from increasing demand for:
- Vaccine storage and distribution
- Diagnostic and lab infrastructure
- Hospital modernization
Its niche focus on cold chain and turnkey execution provides differentiation.
Key Strengths
- Strong expertise in medical cold chain technology
- Integrated turnkey healthcare solutions model
- Wide and diversified product portfolio
- Established presence with institutional clients
- Regulatory-compliant products (WHO, ISO standards)
- Nationwide service and support infrastructure
Insights of Marken Healthtech Limited
Last Funding Round – Marken Healthtech
The company’s last funding round was completed at an approximate valuation of ~₹200 crore. This round marks a key milestone in its capital-raising journey, reflecting its current scale and positioning within the market.
Financial Snapshot (₹ Crore)
| Particulars | FY25 |
|---|---|
| Revenue | 118.41 |
| EBITDA | 22.10 |
| PAT | 7.41 |
Industry Overview
The medical equipment and healthcare infrastructure industry in India is a fast-growing and strategically important sector, driven by rising healthcare demand, increasing government spending, and a strong push toward domestic manufacturing. The industry includes medical devices, cold-chain equipment, diagnostics infrastructure, and turnkey hospital solutions, with demand coming largely from hospitals, laboratories, and government healthcare programs.
India has historically depended on imports for a significant portion of its medical equipment needs, but recent initiatives such as Make in India and production-linked incentives (PLI) are encouraging local manufacturing. This shift is creating opportunities for domestic players to scale and compete with global manufacturers.
Key Highlights
- Growth driven by increasing healthcare expenditure and insurance penetration
-
Rising demand for:
- Vaccine storage and cold-chain solutions
- Diagnostic and laboratory infrastructure
- Hospital modernization and expansion
-
Strong government support through:
- Infrastructure spending
- Subsidies and manufacturing incentives
- Industry is largely B2B and tender-driven
- High importance of quality certifications and compliance standards
Challenges
- Competition from global players and low-cost imports
- Regulatory and certification requirements
- Long sales cycles due to institutional procurement processes
- Working capital intensity in government contracts
Overall, the sector offers strong long-term growth potential, with success dependent on execution capabilities, technological differentiation, and the ability to scale efficiently in a competitive and regulated environment.
Financial Charts of Marken Healthtech Limited
Balance Sheet of Marken Healthtech Limited
Profit and Loss of Marken Healthtech Limited
Ancillary of Marken Healthtech Limited
Ratio Analysis
Peers
Industry Benchmarking
Segment Revenue
Subsidaries
Security Allotment
Corporate Governance
Team Management Details
FAQs of Marken Healthtech Limited
-
How to buy Marken Healthtech Limited?
Below are three ways through which you can purchase Marken Healthtech Limited:
- We at Altius Investech have many actively traded scripts and are market makers of unlisted shares. To check out all the unlisted shares traded. (Click on link). To submit a request to buy Marken Healthtech Limited, please click on the trade button at the top of this page
- Additionally, you can download our app from your play store or app store, register on our application, and engage in active trading there.
Download the Altius App here https://onelink.to/hf4m72 - You can also reach out to us at : +91 8240614850 / +91 8240861716
-
How to sell Marken Healthtech Limited?
Below are three ways through which you can sell Marken Healthtech Limited:
- We at Altius Investech have many actively traded scripts and are market makers of unlisted shares. To check out all the unlisted shares traded. (Click on link). To submit a request to sell Marken Healthtech Limited, please click on the trade button at the top of this page
- Additionally, you can download our app from your play store or app store, register on our application, and engage in active trading there.
Download the Altius App here https://onelink.to/hf4m72 - You can also reach out to us at : +91 8240614850 / +91 8240861716
-
What is the price of Marken Healthtech Limited?
We provide a two way quote on all the shares we deal in. Your buy price for Marken Healthtech Limited is ₹N/A and your sell price for Marken Healthtech Limited is ₹N/A. The price is based on our estimates and market conditions.
-
What is the lock-in period of Marken Healthtech Limited?
The lock-in period for Marken Healthtech Limited varies depending on the category of investors:
- For retail Investors, HNIs, or Body Corporates, the lock-in period is 6 months from the date of the listing of Marken Healthtech Limited
- For Venture Capital Funds or Foreign Venture Capital Investors, there is a lock-in period of 6 months from the date of acquisition of Marken Healthtech Limited
- For AIF-II (Alternative Investment Funds - Category II), there is no lock-in period
August 2021 saw the introduction of this regulation by SEBI. The purpose of the regulation change, which lowered the lock-in period from a year to six months, was to incentivize additional investments in firms getting ready for initial public offerings, or IPOs. Since its introduction, a number of Portfolio Management Services (PMS) have advised their clients to purchase Pre-IPO shares in order to take advantage of the advantages associated with early-stage investments. This reduction in the lock-in period is considered as a significant step forward.
-
How is the Marken Healthtech Limited price calculated?
Fundamental & Comparative valuation models and the forces of demand and supply in the market for unlisted shares dictate the price. These prices are based on our estimates and transaction history of Marken Healthtech Limited. The price is also determined from the most recent funding round for Marken Healthtech Limited. This provides us with a benchmark valuation, offering a clear indication of the company's current market value as perceived by investors and industry experts.
-
What are the lot sizes of Marken Healthtech Limited?
We can generally arrange lot sizes starting with an investment of INR 20,000. To confirm the lot sizes of Marken Healthtech Limited with us kindly click here.
-
What are the financials of Marken Healthtech Limited?
The financials of Marken Healthtech Limited which includes the P/L of Marken Healthtech Limited and the Balance Sheet of Marken Healthtech Limited is in the financials section (Click on link).
-
Where can I find the annual report of Marken Healthtech Limited?
The annual report of Marken Healthtech Limited is available in the annual report section (Click on link).
-
Is buying Marken Healthtech Limited legal in India?
Yes, buying and selling unlisted shares in India is indeed 100% legal. This activity is regulated and governed under the guidelines provided by the Securities and Exchange Board of India (SEBI). Investors and traders must adhere to these regulations and guidelines to ensure compliance with legal and financial standards. It's important for participants in the unlisted share market to be aware of and understand these regulations to engage in transactions legally and securely.
-
Short-term Capital Gain taxes to be paid on Marken Healthtech Limited?
When you sell unlisted shares within a period of two years from the date of acquisition, any profit earned from the sale is classified as Short-term Capital Gain (STCG). This gain is then added to your total income for that financial year. The tax on this short-term capital gain is calculated based on your applicable individual income tax slab rates. Therefore, the rate at which you will pay tax on the STCG from unlisted shares depends on your total income, including this gain, and the tax slab it falls under as per the prevailing income tax laws in India. It's important for investors to consider these tax implications when engaging in transactions involving unlisted shares.
-
Long-term Capital Gain taxes to be paid on Marken Healthtech Limited and how are They Taxed?
Long-term Capital Gains (LTCG) on unlisted shares in India refer to the profits earned from the sale of unlisted shares that have been held for more than two years. The key aspects of LTCG on unlisted shares include:
- Tax Rate: LTCG on unlisted shares is taxed at a rate of 20%.
- Indexation Benefit: This is a significant advantage for investors. Indexation allows for adjusting the purchase price of the shares for inflation, which can reduce the taxable gain.
- Importance for Investors: Understanding LTCG is crucial, especially for High Net-worth Individuals (HNIs) and retail investors, as it impacts their investment strategy and tax planning. Knowing these details helps in making informed investment decisions.
- Calculation: LTCG is calculated by subtracting the indexed cost of acquisition (the purchase price adjusted for inflation) from the sale price of the shares. The profit thus calculated is subject to a 20% tax.
- Applicability: LTCG tax is applicable to profits from the sale of unlisted shares held for more than two years.
- Relevance: This tax is particularly relevant to investors in the unlisted share market, including those considering selling their holdings after a period of more than two years.
-
Applicability of Taxes on Marken Healthtech Limited once it is listed?
When shares initially bought in the unlisted market become listed, the taxation rules change significantly if these shares are sold through a stock exchange. Here's what investors need to know:
Transition to Listed Market Tax Rates: Once unlisted shares are listed on the stock exchange and subsequently sold, the tax rates applicable to listed securities come into effect. This shift means that the favourable tax treatments for listed shares, as per the prevailing tax laws, will apply.
Taxation Based on Holding Period: The crucial factor in determining the type of capital gains tax (Long-term or Short-term) is the holding period of the shares. Importantly, this period is calculated from the original purchase date when the shares were unlisted.
Long-term vs. Short-term Capital Gains: If the shares are sold after being held for more than one year from the date of purchase (including the period when they were unlisted), they are subject to Long-term Capital Gains (LTCG) tax.
Conversely, if sold within one-year, Short-term Capital Gains (STCG) tax rates apply.
Significance for Investors: This information is vital for investors in the unlisted market, as it impacts their tax planning and decision-making process. Understanding these nuances ensures that investors can strategically plan the sale of their shares post-listing to optimize tax implications.
Advice for Investors: It's advisable for investors to keep a record of their purchase dates and monitor the listing dates closely. Additionally, staying updated with the latest tax regulations or consulting with a financial advisor is recommended for accurate tax calculations and compliance. -
How does Altius Investech source Marken Healthtech Limited?
At Altius Investech, our approach to sourcing Boat Unlisted Share (Imagine Marketing) involves a strategic and direct method. Primarily, we acquire these shares from the below key groups:
Employees of the Company: Employee stock option plans (ESOPs) or other compensation packages frequently include shares for firm employees. For a various reasons, such as including portfolio diversification or financial considerations, some of these employees may eventually choose to sell their shares. We engage with these employees, providing them a platform to sell their shares.
Initial Investors: These are the angel or early-stage investors who provided capital to the business in its early stages. These original investors may look to sell all or part of their ownership position in the company as it develops and flourishes. This might be done for various reasons such as in order to maximise their investment, reallocate resources, or make other calculated financial decisions.
Funding rounds and VC funds: Altius Investech sources the shares from private placement rounds in which private companies seek to obtain capital from the market. Through our platform, venture capital funds can liquidate their shares and we receive the inventory from them when they decide to sell a portion of their ownership through block trades.
By establishing connections with these groups, Altius Investech guarantees our clients a steady and dependable supply of Boat Unlisted Share (Imagine Marketing). This process not only makes it easier for employees and initial investors in liquidating their assets, but it also gives our clients access to shares that aren't often found on the open market. Our platform effectively facilitates a win-win situation for both buyers and sellers. -
How to trust Altius Investech before buying Marken Healthtech Limited from its platform?
Altius Investech stands at being India's fastest growing and leading marketplace for buying and selling unlisted shares. We believe in enabling access to alternative sources of investments at lower entry barriers to private equity investments.
With more than 25 years of experience, Altius Investech has carved a niche in the financial market by serving more than 8000 clients. The incredible journey is further highlighted by the vast number of transactions that Altius Investech has facilitated transactions that have already exceeded 300 crores.
For investors Altius Investech curates investment opportunities in companies at reasonable valuations which are on the verge of an IPO leading to massive value unlocking. Investments are backed by thorough research and sound investment thesis, with a time bound exit plan.
For ESOP Shareholder and existing Investors, we assist them to liquidate their shares even if they are not publicly traded by creating a platform where we find the right buyers and sellers for the best prices.
Altius Investech have been featured in top media news outlets like Economic Times, Financial Express, Money control. Check out about us on these - leading publications (Click on link) Our journey over these years has not just been about numbers; it's been about building trust and reliability.
We at Altius Investech are dedicated to upholding the greatest levels of ethics and transparency, making sure that your investment experience is not only profitable but also safe and reliable.
Press of Marken Healthtech Limited
Featured Blogs of Marken Healthtech Limited
Annual Report of Marken Healthtech Limited
Company Information of Marken Healthtech Limited
Featured Companies


